Nicotine and Testosterone: Does It Raise or Lower Levels?

Smokers consistently show higher total testosterone in blood tests compared to non-smokers, with a meta-analysis of over 13,000 men finding an average increase of roughly 1.5 nmol/L across 22 studies. But that headline number obscures a genuinely strange situation: nicotine directly poisons the cellular machinery that makes testosterone, while simultaneously blocking the enzyme that breaks it down into estrogen. The net effect on what your body can actually use is far less clear-cut than the blood-test numbers suggest, and it depends heavily on dose, duration, and the delivery method involved.

What Blood Tests Actually Show in Smokers

The observational evidence is surprisingly consistent. Across dozens of studies and tens of thousands of men, cigarette smokers tend to have higher circulating total testosterone and free testosterone than non-smokers. A systematic review and meta-analysis pooling 22 studies found that male smokers averaged about 1.5 nmol/L higher total testosterone than non-smokers.¹ A separate study of over 3,000 men found that smoking was an independent predictor of higher total and free testosterone even after adjusting for age, body mass, blood sugar, and alcohol intake.²

A large cross-sectional study of middle-aged men found that smokers had roughly 9% higher testosterone, 14% higher DHT, and 33% higher androstenedione compared to non-smokers, independent of body weight and age. Their adrenal androgens like DHEA and DHEAS were also elevated, by about 18% and 13% respectively.³ So the boost is not limited to testosterone alone; the entire androgen pathway seems upregulated in smokers.

Here is where it gets counterintuitive: within smokers, heavier smoking does not mean even higher testosterone. The study that found the overall boost also reported that both total and free testosterone were negatively correlated with the amount of tobacco exposure.² In other words, light-to-moderate smokers had the biggest testosterone advantage over non-smokers, while heavy smokers saw that advantage erode. This pattern points toward a dose-dependent mechanism with a ceiling and eventual reversal, which is exactly what more recent research has confirmed.

The Dose-Response Curve Has a Tipping Point

A study using NHANES data from over 4,000 men measured serum cotinine, a stable breakdown product of nicotine that reflects recent nicotine exposure. After adjusting for a long list of confounders, the researchers found a positive association between cotinine levels and total testosterone up to a point. Men in the highest exposure quartile had roughly 36 ng/dL higher testosterone than those in the lowest quartile. But the relationship was not a straight line: there was an inflection point at a serum cotinine level of 487 ng/mL. Beyond that threshold, testosterone levels actually declined as cotinine continued to rise.⁴

That inflection point is meaningful in practical terms. A serum cotinine of 487 ng/mL corresponds roughly to heavy regular smoking. So moderate nicotine exposure is associated with higher testosterone, but pushing past a certain level of intake flips the relationship. This nonlinear pattern helps explain why the population-level finding (smokers have higher testosterone) coexists with the cellular-level finding that nicotine is toxic to testosterone-producing cells. At lower exposures, the mechanisms that raise circulating testosterone win out. At higher exposures, the damage starts to dominate.

Why Nicotine Raises Circulating Testosterone Despite Being Toxic to the Cells That Make It

The paradox resolves once you understand that nicotine affects multiple parts of the testosterone system simultaneously, and the effects push in opposite directions.

The most likely explanation for the rise in circulating testosterone is nicotine’s ability to block aromatase, the enzyme responsible for converting androgens into estrogens. In tissue preparations, nicotine and its metabolite cotinine competitively inhibited the conversion of testosterone to estrogen.⁵ Brain imaging in baboons showed that nicotine reduced aromatase activity in key brain regions in a dose-dependent manner.⁶ A review of the evidence concluded that many of the sex differences seen in smoking’s health effects may stem from this aromatase-inhibiting property.⁷

If less testosterone is being converted to estrogen, more of it stays in the bloodstream. This is essentially the same mechanism that pharmaceutical aromatase inhibitors use, though nicotine’s effect is weaker and less targeted. It is probably the single biggest reason smokers show higher testosterone on standard blood panels.

Working against this, nicotine is directly harmful to the Leydig cells in the testes where testosterone is actually manufactured. In mouse Leydig cells, both nicotine and cotinine reduced testosterone production stimulated by luteinizing hormone by 50 to 70%.⁸ Rat studies showed nicotine competitively inhibiting multiple enzymes in the testosterone production pathway.⁹ So nicotine hampers the manufacturing process while simultaneously slowing the breakdown of whatever gets manufactured. At moderate exposure levels, the reduced breakdown outweighs the reduced production. Past the tipping point described earlier, the production damage catches up.

The SHBG Problem and Whether the Testosterone Boost Is Real

There is an important wrinkle that complicates the “smokers have higher testosterone” finding: sex hormone-binding globulin, or SHBG. This is a protein in the blood that binds to testosterone and makes it unavailable for the body to use. Only testosterone that is not bound to SHBG is biologically active.

Smokers tend to have higher SHBG along with their higher total testosterone. In one study comparing 71 smokers to 44 non-smokers, total testosterone was meaningfully higher in smokers (about 18.5 vs. 15.1 nmol/L) and free testosterone was also higher. But bioavailable testosterone, the fraction the body can actually use, showed no significant difference between the two groups.¹⁰ The researchers concluded that smoking’s apparent testosterone boost may operate largely through changes in SHBG levels rather than through a genuine increase in the hormone’s biological activity.

If this finding holds broadly, it means the elevated testosterone numbers on a smoker’s blood panel could be somewhat misleading. The body may not “see” any more usable testosterone than a non-smoker has. This is a critical distinction for anyone who encounters the factoid that smoking raises testosterone and starts thinking of it as an androgen-boosting strategy. The total testosterone number goes up, but the testosterone that matters for muscle, mood, and sexual function may not.

Nicotine’s Effect on the Hormonal Control System

Testosterone production is regulated by a feedback loop running from the brain’s hypothalamus to the pituitary gland to the testes. Luteinizing hormone, released in pulses by the pituitary, is the main signal telling the testes to make testosterone. Nicotine interferes with this signaling in a sex-specific way.

In male non-smokers, nicotine significantly lengthened the gap between LH pulses, effectively slowing the signal that drives testosterone production. In male smokers, this effect did not occur, suggesting tolerance had developed. But when smokers quit, that tolerance disappeared within just one week, meaning their LH pulsatility became vulnerable to nicotine’s suppressive effect again.¹¹ Interestingly, nicotine did not affect LH pulsatility in women at all, whether they were smokers or non-smokers.

This tolerance effect adds another layer to the paradox. A first-time nicotine user might experience suppressed LH and, in theory, reduced testosterone signaling. A habitual user develops tolerance to that specific effect, while the aromatase-inhibiting and SHBG-raising mechanisms continue. The hormonal picture is not static; it shifts as the body adapts to chronic nicotine exposure.

What Happens in Women

The testosterone story in women diverges from men in important ways. The same meta-analysis that found a clear testosterone boost in male smokers found no statistically significant association in women across six studies involving over 6,000 subjects.¹ However, a more targeted meta-analysis focused on premenopausal women found a small but statistically significant increase in testosterone among smokers, along with elevated DHEAS levels.¹²

The broader hormonal shift in women who smoke appears to be anti-estrogenic rather than strongly pro-androgenic. Nicotine pushes the androgen-to-estrogen ratio higher throughout a woman’s life, largely because of the aromatase inhibition described earlier.¹³ This shift has clinical consequences that go beyond testosterone levels: it is linked to earlier menopause, reduced bone density, and altered menstrual patterns. The LH pulsatility suppression that nicotine causes in men does not appear to affect women, suggesting the central nervous system pathways involved are sexually dimorphic.

Does the Delivery Method Matter

Most of the evidence linking nicotine to testosterone comes from cigarette smokers, which means the effects could be driven partly by the thousands of other chemicals in cigarette smoke rather than by nicotine alone. Teasing these apart is difficult, but a few studies offer clues.

Water-pipe smoking, which delivers nicotine through a different combustion and filtration process, showed no significant effect on total testosterone, free testosterone, or bioavailable testosterone in a study of men in Qatar, even after comparing light and heavy water-pipe users to non-users.¹⁴ This does not prove nicotine is innocent, since water-pipe smoking delivers different doses and patterns of nicotine along with a different mix of combustion products, but it does suggest that the cigarette-testosterone link is not universal across all forms of tobacco use.

Nicotine gum provides a cleaner test of nicotine’s isolated effects. In a study of middle-aged men enrolled in a smoking cessation trial, those who quit smoking and used nicotine gum saw a significant drop in salivary androstenedione, a testosterone precursor. Importantly, the same drop occurred in men who quit smoking without any nicotine replacement. Men who continued smoking saw no change. And salivary testosterone itself was not significantly affected by any change in smoking status.¹⁵ The fact that quitting produced the same androstenedione drop regardless of whether nicotine gum replaced cigarettes suggests that other components of cigarette smoke, not nicotine alone, may be responsible for at least some of the androgen elevation seen in smokers.

For people using nicotine pouches, vaping, or patches without a history of cigarette smoking, the honest answer is that we do not have large human studies directly measuring testosterone effects from these products. The cellular and enzyme-level effects of nicotine (aromatase inhibition, Leydig cell toxicity) would still apply regardless of how the nicotine reaches the bloodstream. But the magnitude, especially of the aromatase-related testosterone boost, could differ substantially without the synergy of thousands of other smoke compounds.

Acute Effects Versus Chronic Exposure

A single dose of nicotine appears to produce a short-lived hormonal spike. A study in healthy baseball players found that acute nicotine intake led to significant changes in testosterone and cortisol levels, along with altered sympathetic nervous system activity and enhanced cognitive performance. No increase in muscle strength was observed despite the hormonal shift.¹⁶ This is consistent with what you would expect from a stimulant that activates the stress-response system: a temporary bump in several hormones that fades as the drug wears off.

Chronic exposure tells a different story. The tolerance that develops to nicotine’s LH-suppressing effects within weeks of regular use, combined with cumulative oxidative damage to testicular tissue, means the hormonal profile of a long-term user is not simply the acute effect repeated daily. Animal studies show that chronic nicotine exposure increases reactive oxygen species in the testes, triggers tissue hypoxia, and disrupts the testicular microenvironment, with partial recovery observed after cessation.¹⁷ The distinction matters practically: someone using nicotine intermittently for a performance edge would face a very different biological picture than a daily smoker of 20 years.

Fertility Is a Separate and Worse Story

Even if the testosterone number on a blood panel looks favorable, the downstream effects on reproductive function tell a bleaker story. Nicotine can reduce sperm count, motility, and functionality.¹⁸ The oxidative stress and tissue hypoxia in the testes from chronic nicotine exposure do not just affect testosterone-producing cells; they also damage the cells responsible for making sperm and the structural proteins within sperm nuclei.

The reversibility question matters here. The same mouse study that documented nicotine-driven oxidative damage in testicular tissue found partial recovery after cessation, but the recovery was incomplete, and some epigenetic changes persisted.¹⁷ For men concerned about fertility, the takeaway is that even if your total testosterone looks fine or even elevated from nicotine use, the health of the tissue producing both testosterone and sperm may be deteriorating under the surface. A testosterone blood test does not capture that damage.

Why “Nicotine Boosts Testosterone” Is a Dangerous Oversimplification

The internet fitness community has latched onto the population-level finding that smokers have higher testosterone, sometimes using it to justify nicotine pouch or snus use as a testosterone optimization strategy. The problems with this reasoning stack up quickly. The “boost” may be largely an artifact of increased SHBG, meaning the biologically active testosterone fraction does not change. The dose-response relationship is nonlinear and reverses at heavy use. The cellular-level evidence shows nicotine directly impairing the machinery that produces testosterone. The fertility consequences are unambiguously negative. And much of the evidence comes from cigarette smokers, making it unclear how much transfers to isolated nicotine products.

There is also the confounding problem that no observational study can fully escape: smokers differ from non-smokers in dozens of ways beyond nicotine exposure. They tend to have different stress profiles, dietary habits, sleep patterns, and body compositions. Even after statistical adjustment for known confounders, residual confounding could inflate the apparent testosterone difference. The fact that the testosterone boost in women is much smaller or absent, despite similar nicotine exposure from the same number of cigarettes, suggests that the mechanism involves interactions with male-specific physiology that simple nicotine exposure does not fully explain.

What Quitting Does to Hormone Levels

The evidence on what happens to testosterone after quitting is surprisingly thin. The nicotine gum study found that quitting dropped androstenedione levels significantly but left salivary testosterone unchanged, regardless of whether men used nicotine replacement or went cold turkey.¹⁵ The rapid loss of LH tolerance within one week of quitting, documented in the LH pulsatility study, suggests the hormonal control system resets quickly.¹¹

If the elevated total testosterone in smokers is primarily driven by aromatase inhibition and SHBG changes, quitting would be expected to normalize both fairly quickly as nicotine and cotinine clear the body. The testicular oxidative damage and epigenetic changes from chronic use take longer to resolve, as the animal cessation data suggests. For men who have smoked for years and are considering quitting, a temporary dip in total testosterone on blood work would not be surprising, but it would likely reflect the removal of an artificial inflation rather than a genuine loss of hormonal function. The biologically active fraction, which may not have been elevated in the first place, would be less affected.

1
PubMed. Cigarette smoking and testosterone in men and women: A systematic review and meta-analysis of observational studies
2
PubMed. Cigarette smoking has a positive and independent effect on testosterone levels
3
PubMed Central. The relation of smoking, age, relative weight, and dietary intake to serum adrenal steroids, sex hormones, and sex hormone-binding globulin in middle-aged men
4
PubMed Central. Association between serum cotinine and total testosterone in adult males based on NHANES 2011–2016
5
PubMed Central. Nicotine, cotinine, and anabasine inhibit aromatase in human trophoblast in vitro
6
PubMed Central. Nicotine blocks brain estrogen synthase (aromatase): in vivo positron emission tomography studies in female baboons
7
PubMed Central. Potential contribution of aromatase inhibition to the effects of nicotine and related compounds on the brain
8
PubMed. Nicotine and cotinine inhibit steroidogenesis in mouse Leydig cells
9
Journal of Steroid Biochemistry. Nicotine and cotinine inhibit rat testis androgen biosynthesis in vitro
10
PubMed. Effect of cigarette smoking on levels of bioavailable testosterone in healthy men
11
PubMed. Nicotine inhibits pulsatile luteinizing hormone secretion in human males but not in human females, and tolerance to this nicotine effect is lost within one week of quitting smoking
12
PubMed. A Systematic Review and Meta-Analysis of Smoking and Circulating Sex Hormone Levels Among Premenopausal Women
13
PubMed. The influence of smoking and cessation on the human reproductive hormonal balance
14
Tobacco Induced Diseases. Water-pipe smoking and serum testosterone levels in adult males in Qatar
15
PubMed. Relationship of smoking cessation and nicotine gum use to salivary androstenedione and testosterone in middle-aged men
16
PubMed Central. Acute Effects of Nicotine on Physiological Responses and Sport Performance in Healthy Baseball Players
17
Communications Biology. Mechanisms and reversibility of nicotine-induced spermatogenesis impairment and DNA methylation changes
18
PubMed Central. Adverse Effects of Nicotine on Human Sperm Nuclear Proteins